As reimbursement changes and healthcare moves towards value-based models, the clinical laboratory is faced with the challenge of redefining its value outside the cost per test. This session will provide attendees with the opportunity to explore new ways of demonstrating value within the traditional triple aim construct. Through a case study example, the session will demonstrate how an integrative approach to the application of lab data can provide actionable insights to multiple stakeholders that ultimately improve outcomes and downstream costs.
1. Establish the value of the clinical lab in value-based healthcare
2. Discuss how lab data (big & little) can affect clinical outcomes
3. Discuss lab’s leadership role with non-traditional clinical stakeholders